HCW Biologics Inc. (HCWB)
1.18
-0.27
(-18.62%)
USD |
NASDAQ |
Jun 09, 16:00
1.21
+0.03
(+2.54%)
After-Hours: 20:00
HCW Biologics SG&A Expense (Quarterly) : 1.833M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 34.84M |
| Longeveron, Inc. | 2.72M |
| Arrowhead Pharmaceuticals, Inc. | 41.74M |
| Oncolytics Biotech, Inc. | 4.729M |
| Sangamo Therapeutics, Inc. | 6.818M |